93 related articles for article (PubMed ID: 3101608)
1. [Phase I study of a recombinant gamma interferon (S-6810)].
Ogawa M; Takaku F; Maekawa T; Ota K; Ichimaru M; Izuo M; Takakura K; Ikeda S; Koiso K; Machida T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):446-52. PubMed ID: 3101608
[TBL] [Abstract][Full Text] [Related]
2. [Gamma interferon therapy of cancer patients].
Kobayashi Y; Urabe A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):804-9. PubMed ID: 3133983
[TBL] [Abstract][Full Text] [Related]
3. [Phase I-II study of recombinant interferon gamma].
Adachi K; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Nakada H; Tada A; Yamazaki H; Mukaiyama T
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1331-8. PubMed ID: 2988459
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of recombinant human interferon gamma (S-6810) in renal cell carcinoma. Urological Cooperative Study Group of Recombinant Human Interferon Gamma (S-6810)].
Machida T; Koiso K; Takaku F; Ogawa M
Gan To Kagaku Ryoho; 1987 Feb; 14(2):440-5. PubMed ID: 3101607
[TBL] [Abstract][Full Text] [Related]
5. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
[TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
Greenblatt MS; Mangalik A; Ferguson J; Elias L
Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
[TBL] [Abstract][Full Text] [Related]
7. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of high-dose etoposide phosphate in man.
Fields SZ; Budman DR; Young RR; Kreis W; Ingram R; Schulman P; Cherny RC; Wright J; Behr J; Snow C; Schacter LP
Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
Kurzrock R; Quesada JR; Rosenblum MG; Sherwin SA; Gutterman JU
Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
[TBL] [Abstract][Full Text] [Related]
11. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
Furue H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
[TBL] [Abstract][Full Text] [Related]
12. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
[TBL] [Abstract][Full Text] [Related]
13. A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
Ohno R; Yamaguchi Y; Toge T; Kinouchi T; Kotake T; Shibata M; Kiyohara Y; Ikeda S; Fukui I; Gohchi A; Sugiyama Y; Saji S; Hazama S; Oka M; Ohnishi K; Ohhashi Y; Tsukagoshi S; Taguchi T
Clin Cancer Res; 2000 Jul; 6(7):2661-9. PubMed ID: 10914707
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
Vadhan-Raj S; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
[TBL] [Abstract][Full Text] [Related]
15. [The clinical phase I study of TNP-351. The TNP-351 Research Committee].
Taguchi T; Niitani H; Furue H; Tsukagoshi S; Kanamaru R; Hasegawa K; Akazawa S; Yoneda S; Tominaga T; Sasaki T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102
[TBL] [Abstract][Full Text] [Related]
16. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
van der Burg M; Edelstein M; Gerlis L; Liang CM; Hirschi M; Dawson A
J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
[TBL] [Abstract][Full Text] [Related]
17. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
Silver HK; Connors JM; Salinas FA
Cancer Treat Rep; 1985; 69(7-8):743-50. PubMed ID: 4016785
[TBL] [Abstract][Full Text] [Related]
18. [Phase II studies of interferon alpha-2 Sch 30500 in advanced gastrointestinal carcinoma].
Furue H
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1625-9. PubMed ID: 3896154
[TBL] [Abstract][Full Text] [Related]
19. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.
Quesada JR; Kurzrock R; Sherwin SA; Gutterman JU
J Biol Response Mod; 1987 Feb; 6(1):20-7. PubMed ID: 3104544
[TBL] [Abstract][Full Text] [Related]
20. A phase 1 study of recombinant interferon-gamma given intravenously by portable mini-pump: a preliminary report.
Sriskandan K; Garner P; Watkinson J; Gerlis L; Tee DE
Int J Clin Pharmacol Res; 1984; 4(6):469-74. PubMed ID: 6241930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
